Celaid Therapeutics is a Japan-based biotechnology company, which has developed a platform technology to efficiently expand hematopoietic stem cells ex vivo without choosing its origins, including bone marrow, cord blood, or peripheral blood. By using the novel technology, we are developing a cell therapy product that brings HSC transplantation to the next level and helps patients with blood disorders. Our technology has many potential applications including gene/cell therapy that utilize gene editing on HSC.
Our mission is to improve QOL of patients, their families, and HSC donors all over the world.
Location: Japan, Bunkyo
Employees: 11-50
Founded date: 2020
Investors 1
| Date | Name | Website |
| 30.06.2021 | The Univer... | ut-ec.co.j... |
Mentions in press and media 3
| Date | Title | Description | Source |
| 28.03.2024 | Kobe Medical Industrial City Promotion Organization and Celi... | Kobe Medical Industrial City Promotion Organization and Celide Therapeutics sign a joint research ag... | re-how.net... |
| 22.03.2024 | Ceride Therapeutics Co., Ltd. selected for NEDO’s Deep Tech ... | Ceride Therapeutics Co., Ltd. selected for NEDO’s Deep Tech Startup Support Project (DTSU) *View in ... | re-how.net... |
| 14.12.2023 | C4U and Celide Therapeutics sign joint research agreement to... | Ceride Therapeutics Co., Ltd. C4U and Celide Therapeutics sign joint research agreement to realize h... | re-how.net... |